Vanguard Group’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-3,524,390
Closed -$62.6M 4172
2018
Q3
$62.6M Buy
3,524,390
+394,259
+13% +$6.77M ﹤0.01% 2039
2018
Q2
$43.2M Buy
3,130,131
+750,967
+32% +$8.91M ﹤0.01% 2195
2018
Q1
$21.6M Buy
2,379,164
+749,755
+46% +$4.14M ﹤0.01% 2464
2017
Q4
$6.97M Buy
1,629,409
+127,562
+8% +$608K ﹤0.01% 2996
2017
Q3
$2.12M Buy
1,501,847
+174,550
+13% +$243K ﹤0.01% 3380
2017
Q2
$1.99M Sell
1,327,297
-302,539
-19% -$650K ﹤0.01% 3382
2017
Q1
$4.19M Buy
1,629,836
+143,497
+10% +$332K ﹤0.01% 3127
2016
Q4
$3.79M Buy
1,486,339
+32,961
+2% +$94.6K ﹤0.01% 3158
2016
Q3
$4.49M Buy
1,453,378
+156,960
+12% +$489K ﹤0.01% 3057
2016
Q2
$4.16M Buy
1,296,418
+6,144
+0.5% +$22.5K ﹤0.01% 3070
2016
Q1
$4M Buy
1,290,274
+59,015
+5% +$193K ﹤0.01% 3078
2015
Q4
$4.94M Buy
1,231,259
+21,788
+2% +$100K ﹤0.01% 2988
2015
Q3
$5.54M Buy
1,209,471
+53,522
+5% +$280K ﹤0.01% 2918
2015
Q2
$6M Buy
1,155,949
+78,723
+7% +$472K ﹤0.01% 2921
2015
Q1
$6.74M Buy
1,077,226
+55,842
+5% +$322K ﹤0.01% 2841
2014
Q4
$6.42M Buy
1,021,384
+24,795
+2% +$151K ﹤0.01% 2763
2014
Q3
$6.06M Sell
996,589
-35,655
-3% -$244K ﹤0.01% 2732
2014
Q2
$6.8M Buy
1,032,244
+19,060
+2% +$215K ﹤0.01% 2694
2014
Q1
$24.1M Buy
1,013,184
+121,680
+14% +$1.76M ﹤0.01% 2123
2013
Q4
$9.53M Sell
891,504
-22,073
-2% -$244K ﹤0.01% 2489
2013
Q3
$12.2M Buy
913,577
+39,298
+4% +$621K ﹤0.01% 2304
2013
Q2
$11.5M Buy
+874,279
New +$11.8M ﹤0.01% 2274

Other funds holding ECYT